FdaApplication

ANDA 202524

Back to search

Identifiers

Properties

PropertyValue
applicant_nameROUSES POINT PHARMACEUTICALS LLC
application_typeANDA
approval_date2012-08-27

Products (2)

ProductActive ingredientStrengthDosage form
LEVETIRACETAMLEVETIRACETAM500MGTABLET, EXTENDED RELEASE;ORAL
LEVETIRACETAMLEVETIRACETAM750MGTABLET, EXTENDED RELEASE;ORAL

2 products